Atlas Trials

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Clinical trial NCT04425239 · COMPLETED

Trial details

NCT number
NCT04425239
Sponsor
National Cancer Institute, Naples
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Stage IV
Start date
2018-05-21
Primary completion
2021-07-02
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.